Testing effectiveness (Phase 2)Ended earlyNCT01762033What this trial is testingASONEP™ to Treat Unresectable and Refractory Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma Lpath, Inc. 40
Early research (Phase 1)Looking for participantsNCT05856981What this trial is testingPhase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid TumorsWho this might be right forSolid Tumor, AdultMetastatic Solid TumorRefractory Cancer+4 more Sairopa B.V. 130
Large-scale testing (Phase 3)Study completedNCT02627963What this trial is testingCompare Tivozanib Hydrochloride to Sorafenib in Participants With Refractory Advanced Renal Cell Carcinoma (RCC)Who this might be right forCarcinoma, Renal Cell AVEO Pharmaceuticals, Inc. 350
Early research (Phase 1)Study completedNCT01497821What this trial is testingAMG 172 First in Human Study in Patients With Kidney CancerWho this might be right forRenal Cell AdenocarcinomaClear Cell Renal CarcinomaClear Cell Renal Cell Carcinoma+1 more Amgen 37
Early research (Phase 1)Study completedNCT01331135What this trial is testingAflac ST0901 CHOANOME - Sirolimus in Solid TumorsWho this might be right forEwing's SarcomaOsteosarcomaAstrocytoma+13 more Emory University 18
Testing effectiveness (Phase 2)Study completedNCT00787761What this trial is testingEarly Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological CancerWho this might be right forMyeloproliferative DisordersKidney CancerLeukemia+4 more Northside Hospital, Inc. 24
Early research (Phase 1)Study completedNCT00625456What this trial is testingSafety Study of Recombinant Vaccinia Virus to Treat Refractory Solid TumorsWho this might be right forMelanomaLung CancerRenal Cell Carcinoma+1 more Jennerex Biotherapeutics 23
Early research (Phase 1)Study completedNCT00001683What this trial is testingA Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic CancerWho this might be right forLymphomaMelanomaNeoplasm Metastasis+1 more National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Study completedNCT00027820What this trial is testingTotal-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney CancerWho this might be right forAdult Acute Myeloid Leukemia in RemissionChildhood Acute Lymphoblastic Leukemia in RemissionChildhood Acute Myeloid Leukemia in Remission+27 more Fred Hutchinson Cancer Center 106
Testing effectiveness (Phase 2)Study completedNCT00057889What this trial is testingMonoclonal Antibody Therapy in Treating Patients With Metastatic Renal Cell CancerWho this might be right forKidney Cancer National Institutes of Health Clinical Center (CC)
Early research (Phase 1)Not Yet RecruitingNCT06383507What this trial is testingA Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid TumorsWho this might be right forMetastatic TumorAdvanced Solid TumorRenal Cell Carcinoma+4 more Zhejiang University 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT06480565What this trial is testingA Phase 1/2 Trial of ADI-270 in ccRCCWho this might be right forClear Cell Renal Cell Carcinoma Adicet Therapeutics 60
Not applicableStudy completedNCT00005799What this trial is testingFludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney CancerWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+42 more Fred Hutchinson Cancer Center 55
Early research (Phase 1)Looking for participantsNCT05433142What this trial is testingStudy of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell CarcinomaWho this might be right forClear Cell Renal Cell Carcinoma Xencor, Inc. 307
Testing effectiveness (Phase 2)Ended earlyNCT03435640What this trial is testingREVEAL Study of NKTR-262 in Combination With NKTR-214 and Nivolumab in Patients With Locally Advanced / Metastatic Solid Tumor MalignanciesWho this might be right forMelanomaMerkel Cell CarcinomaTriple Negative Breast Cancer+4 more Nektar Therapeutics 64
Early research (Phase 1)Study completedNCT02390843What this trial is testingSimvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS TumorsWho this might be right forRetinoblastomaClear Cell SarcomaRenal Cell Carcinoma+9 more Emory University 13
Testing effectiveness (Phase 2)WithdrawnNCT01834183What this trial is testingTivozanib + Gemcitabine in Metastatic RCCWho this might be right forRenal Cell Carcinoma Dana-Farber Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT02335918What this trial is testingA Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid TumorsWho this might be right forSquamous Cell Carcinoma of the Head and Neck (SCCHN)Ovarian Carcinoma-Enrollment CompletedColorectal Cancer (CRC)-Enrollment Completed+2 more Celldex Therapeutics 175
Testing effectiveness (Phase 2)Active Not RecruitingNCT02867592What this trial is testingCabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare TumorsWho this might be right forAdrenal Cortical CarcinomaAlveolar Soft Part SarcomaCentral Nervous System Neoplasm+41 more National Cancer Institute (NCI) 109
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130